Table 2 Medication regimens of 47 patients who developed onychopathy
Regimen | Number | Previous regimens |
|---|---|---|
DTX (60-80)/q3w | 20 | Carboplatin + PTX (3) |
Gefitinib (1) | ||
Carboplatin + gemcitabine (1) | ||
DTX (1) | ||
FEC (10) | ||
FP (1) | ||
Vinorelbine (1) | ||
Trastuzumab (1) | ||
XP (1) | ||
DTX (70)/q3w/prednisolone | 4 | Goserelin (2) |
Leuprorelin (1) | ||
Estramustine (1) | ||
S-1 (80)/cisplatin (40)/DTX (40)/q6w | 10 | None (10) |
S-1 (80)/DTX (40)/q3w | 3 | Cisplatin + irinotecan (1) |
S-1 + cisplatin + DTX (1) | ||
None (1) | ||
DTX (30)/qw | 1 | None (1) |
DTX (20-40)/q2w | 3 | Tamoxifen + goserelin (1) |
PTX (1) | ||
None (1) | ||
DTX (35)/qw/estramustine (560) | 1 | PTX + estramustine (1) |
DTX (40)/q3w/carboplatin | 4 | Carboplatin + PTX (1) |
None (3) | ||
Irinotecan (60)/DTX (35)/q2w | 1 | AP (1) |